(Q43735119)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11553616%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

title

Exposure to long chain polyunsaturated fatty acids triggers rapid multimerization of synucleins (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11553616%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

0 references

1 reference

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11553616%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

David F. Clayton

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11553616%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

author name string

Perrin RJ

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11553616%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

Woods WS

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11553616%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

language of work or name

English

0 references

publication date

11 September 2001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11553616%20AND%20SRC:MED&resulttype=core&format=json

Journal of Biological Chemistry

11 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11553616%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

volume

276

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11553616%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

page(s)

41958-41962

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11553616%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

issue

45

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11553616%20AND%20SRC:MED&resulttype=core&format=json

The synucleins: a family of proteins involved in synaptic function, plasticity, neurodegeneration and disease.

11 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M105022200

Stabilization of alpha-synuclein secondary structure upon binding to synthetic membranes

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M105022200

Synucleins are expressed in the majority of breast and ovarian carcinomas and in preneoplastic lesions of the ovary

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M105022200

Transcriptional suppression of synuclein gamma (SNCG) expression in human breast cancer cells by the growth inhibitory cytokine oncostatin M.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M105022200

Characterization of a novel protein regulated during the critical period for song learning in the zebra finch.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M105022200

Synelfin regulation during the critical period for song learning in normal and isolated juvenile zebra finches.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M105022200

Testosterone regulates alpha-synuclein mRNA in the avian song system

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M105022200

alpha-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with lewy bodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M105022200

Nigral and cortical Lewy bodies and dystrophic nigral neurites in Parkinson's disease and cortical Lewy body disease contain alpha-synuclein immunoreactivity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M105022200

Lewy bodies contain altered alpha-synuclein in brains of many familial Alzheimer's disease patients with mutations in presenilin and amyloid precursor protein genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M105022200

Antibodies to alpha-synuclein detect Lewy bodies in many Down's syndrome brains with Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M105022200

Widespread alterations of alpha-synuclein in multiple system atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M105022200

Glial cytoplasmic inclusions in white matter oligodendrocytes of multiple system atrophy brains contain insoluble alpha-synuclein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M105022200

Filamentous alpha-synuclein inclusions link multiple system atrophy with Parkinson's disease and dementia with Lewy bodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M105022200

Alpha-synuclein immunoreactivity in glial cytoplasmic inclusions in multiple system atrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M105022200

Involvement of alpha-synuclein in Parkinson's disease and other neurodegenerative disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M105022200

Accumulation of NACP/alpha-synuclein in lewy body disease and multiple system atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M105022200

Synucleinopathies: clinical and pathological implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M105022200

Neurodegeneration with brain iron accumulation, type 1 is characterized by alpha-, beta-, and gamma-synuclein neuropathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M105022200

Vascular factors in cognitive impairment--where are we now?

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M105022200

Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M105022200

Mutation in the alpha-synuclein gene identified in families with Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M105022200

Low frequency of alpha-synuclein mutations in familial Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M105022200

The role of the alpha-synuclein gene mutation in patients with sporadic Parkinson's disease in the United Kingdom

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M105022200

The alpha-synuclein Ala53Thr mutation is not a common cause of familial Parkinson's disease: a study of 230 European cases. European Consortium on Genetic Susceptibility in Parkinson's Disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M105022200

alpha-synuclein fibrillogenesis is nucleation-dependent. Implications for the pathogenesis of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M105022200

Both familial Parkinson's disease mutations accelerate alpha-synuclein aggregation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M105022200

Acceleration of oligomerization, not fibrillization, is a shared property of both alpha-synuclein mutations linked to early-onset Parkinson's disease: implications for pathogenesis and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M105022200

Accelerated in vitro fibril formation by a mutant alpha-synuclein linked to early-onset Parkinson disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M105022200

Non-Abeta component of Alzheimer's disease amyloid (NAC) revisited. NAC and alpha-synuclein are not associated with Abeta amyloid.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M105022200

Novel alpha-synuclein-immunoreactive proteins in brain samples from the Contursi kindred, Parkinson's, and Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M105022200

Interaction of human alpha-Synuclein and Parkinson's disease variants with phospholipids. Structural analysis using site-directed mutagenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M105022200

A simple method for the preparation of homogeneous phospholipid vesicles

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M105022200

Conformational properties of alpha-synuclein in its free and lipid-associated states

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M105022200

The antiarrhythmic and anticonvulsant effects of dietary N-3 fatty acids

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M105022200

Endophilin I mediates synaptic vesicle formation by transfer of arachidonate to lysophosphatidic acid.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M105022200

Regulation of phospholipase D2: selective inhibition of mammalian phospholipase D isoenzymes by alpha- and beta-synucleins

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M105022200

Mice lacking alpha-synuclein display functional deficits in the nigrostriatal dopamine system

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M105022200

Synthetic filaments assembled from C-terminally truncated alpha-synuclein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M105022200

Effects of the mutations Ala30 to Pro and Ala53 to Thr on the physical and morphological properties of alpha-synuclein protein implicated in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M105022200

Human recombinant NACP/alpha-synuclein is aggregated and fibrillated in vitro: relevance for Lewy body disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M105022200

Role of cytochrome c as a stimulator of alpha-synuclein aggregation in Lewy body disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M105022200

Axon pathology in Parkinson's disease and Lewy body dementia hippocampus contains alpha-, beta-, and gamma-synuclein

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M105022200

Lipids of nervous tissue: composition and metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M105022200

Alpha-synuclein and the Parkinson's disease-related mutant Ala53Thr-alpha-synuclein do not undergo proteasomal degradation in HEK293 and neuronal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M105022200

Rat alpha-synuclein interacts with Tat binding protein 1, a component of the 26S proteasomal complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M105022200

Ubiquitination of a new form of alpha-synuclein by parkin from human brain: implications for Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M105022200

Oxidative stress induces amyloid-like aggregate formation of NACP/alpha-synuclein in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M105022200

Acrolein is a product of lipid peroxidation reaction. Formation of free acrolein and its conjugate with lysine residues in oxidized low density lipoproteins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M105022200